Chemical Structure : CT-996
CAS No.: 2810808-95-6
货号: PC-26360Not For Human Use, Lab Use Only.
Tifeglipron (CT-996, RO7795081, RG6652) is a potent, selective and orally active glucagon-like peptide 1 receptor (GLP-1R) agonist with EC50 of 0.49 nM.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥2580 | In stock | |
| 10 mg | ¥3980 | In stock | |
| 25 mg | ¥5980 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Tifeglipron (CT-996, RO7795081, RG6652) is a potent, selective and orally active glucagon-like peptide 1 receptor (GLP-1R) agonist with EC50 of 0.49 nM.
CT-996 reduces the β-arrestin recruitment and GLP-1R internalization.
CT-996 suppresses postprandial blood glucose following a mixed meal tolerance test (MMTT) in mice expressing the human GLP-1 receptor and enhances glucose stimulated insulin secretion (GSIS) during an intravenous glucose challenge in obese monkeys.
| 分子量 | 579.60 | |
| 分子式 | C30H31F2N5O5 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
2-(((2S,4S)-4-((2-((2,4-difluorophenoxy)methyl)pyrimidin-4-yl)oxy)-2-methylpiperidin-1-yl)methyl)-1-(((S)-oxetan-2-yl)methyl)-1H-benzo[d]imidazole-6-carboxylic acid |
|
1. Drucker DJ. GLP-1-based therapies for diabetes, obesity and beyond. Nat Rev Drug Discov. 2025 Aug;24(8):631-650.
2. JIAN LUO, et al. Diabetes 14 June 2024; 73 (Supplement_1): 771–P.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright